• Je něco špatně v tomto záznamu ?

Current developments in cell- and biomaterial-based approaches for stroke repair

P. Jendelová, Š. Kubinová, I. Sandvig, S. Erceg, A. Sandvig, E. Syková,

. 2016 ; 16 (1) : 43-56. [pub] 20150930

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc16028166

INTRODUCTION: Stroke is one of the most devastating diseases and a leading cause of mortality worldwide. So far, clinical management of stroke involves surgical clot retrieval or thrombolytic treatment inducing reperfusion of the occluded vessels in the cerebral infarcted area, which is dependent on early intervention following insult. New treatment strategies involve the promotion of angiogenesis and neuroplasticity, stimulation of endogenous neurogenesis, remyelinization, and immunomodulation by means of cell transplantation and sustained drug delivery. AREAS COVERED: This review describes different types of stem cells (endogenous and exogenous neural progenitors, pluripotent stem cell derivatives, mesenchymal stem cells [MSCs], olfactory ensheathing cells) and biomaterials, their routes of administration, means of noninvasive imaging, and the prerequisites and hurdles for the successful translation of the cell therapies to the clinic. EXPERT OPINION: Neural precursors (NPs) derived from pluripotent stem cells, unlike MSCs, can not only remodel the CNS by promoting neuroplasticity, angiogenesis, and immunomodulation, but also replace damaged cells. To transfer NPs into the clinic, step by step guidelines for researchers are identified and discussed.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16028166
003      
CZ-PrNML
005      
20161021121636.0
007      
ta
008      
161005s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1517/14712598.2016.1094457 $2 doi
024    7_
$a 10.1517/14712598.2016.1094457 $2 doi
035    __
$a (PubMed)26419582
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Jendelová, Pavla $u a 1 Institute of Experimental Medicine ASCR, Department of Neuroscience , Prague, Czech Republic +420 2 41 06 22 82 ; +420 2 41 06 27 06 ; jendel@biomed.cas.cz.
245    10
$a Current developments in cell- and biomaterial-based approaches for stroke repair / $c P. Jendelová, Š. Kubinová, I. Sandvig, S. Erceg, A. Sandvig, E. Syková,
520    9_
$a INTRODUCTION: Stroke is one of the most devastating diseases and a leading cause of mortality worldwide. So far, clinical management of stroke involves surgical clot retrieval or thrombolytic treatment inducing reperfusion of the occluded vessels in the cerebral infarcted area, which is dependent on early intervention following insult. New treatment strategies involve the promotion of angiogenesis and neuroplasticity, stimulation of endogenous neurogenesis, remyelinization, and immunomodulation by means of cell transplantation and sustained drug delivery. AREAS COVERED: This review describes different types of stem cells (endogenous and exogenous neural progenitors, pluripotent stem cell derivatives, mesenchymal stem cells [MSCs], olfactory ensheathing cells) and biomaterials, their routes of administration, means of noninvasive imaging, and the prerequisites and hurdles for the successful translation of the cell therapies to the clinic. EXPERT OPINION: Neural precursors (NPs) derived from pluripotent stem cells, unlike MSCs, can not only remodel the CNS by promoting neuroplasticity, angiogenesis, and immunomodulation, but also replace damaged cells. To transfer NPs into the clinic, step by step guidelines for researchers are identified and discussed.
650    _2
$a zvířata $7 D000818
650    _2
$a biokompatibilní materiály $x terapeutické užití $7 D001672
650    _2
$a buněčná a tkáňová terapie $x metody $x trendy $7 D064987
650    12
$a řízená tkáňová regenerace $x přístrojové vybavení $x metody $7 D048091
650    _2
$a lidé $7 D006801
650    _2
$a regenerace nervu $x fyziologie $7 D009416
650    _2
$a neurogeneze $x fyziologie $7 D055495
650    _2
$a neuroplasticita $x fyziologie $7 D009473
650    _2
$a pluripotentní kmenové buňky $x cytologie $x fyziologie $x transplantace $7 D039904
650    _2
$a nika kmenových buněk $x fyziologie $7 D055153
650    _2
$a cévní mozková příhoda $x patofyziologie $x terapie $7 D020521
650    _2
$a tkáňové inženýrství $x přístrojové vybavení $x metody $7 D023822
650    _2
$a tkáňové podpůrné struktury $x chemie $7 D054457
650    _2
$a hojení ran $x fyziologie $7 D014945
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Kubinová, Šárka $u b 2 Institute of Experimental Medicine ASCR, Department of Neuroscience , Prague, Czech Republic.
700    1_
$a Sandvig, Ioanna $u c 3 Norwegian University of Science and Technology, Department of Neuroscience , 7491 Trondheim, Norway.
700    1_
$a Erceg, Slaven $u b 2 Institute of Experimental Medicine ASCR, Department of Neuroscience , Prague, Czech Republic.
700    1_
$a Sandvig, Axel $u c 3 Norwegian University of Science and Technology, Department of Neuroscience , 7491 Trondheim, Norway.
700    1_
$a Syková, Eva $u b 2 Institute of Experimental Medicine ASCR, Department of Neuroscience , Prague, Czech Republic.
773    0_
$w MED00181398 $t Expert opinion on biological therapy $x 1744-7682 $g Roč. 16, č. 1 (2016), s. 43-56
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26419582 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20161005 $b ABA008
991    __
$a 20161021122045 $b ABA008
999    __
$a ok $b bmc $g 1166480 $s 952796
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 16 $c 1 $d 43-56 $e 20150930 $i 1744-7682 $m Expert opinion on biological therapy $n Expert Opin Biol Ther $x MED00181398
LZP    __
$a Pubmed-20161005

Najít záznam

Citační ukazatele

Možnosti archivace